ARCHIVES

NCI Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 33 No. 5 | May 28, 2010

Download PDF Visit The Full Archive

Related Articles

European Treatment Regimen Less Toxic Than American Method

April 26, 2013

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

M.D. Anderson Breast Cancer Studies Promising NEJM Publishes Bonadnna Report

February 27, 1976

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

December 5, 2014

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010